Policy Statements

Genetic Alliance is called on periodically to testify before congressional committees, advisory committees and other deliberative bodies. In addition, Genetic Alliance actively leverages the voices of its members in formal communication with government officials and agencies. Here are some of the statements presented:

Comments to the National Institutes of Health on open access policy – March 20, 2008

Remarks to Capitol Hill staff at the Health IT Now!  Coalition briefing – March 14, 2008

Comments to the Secretary’s Advisory Committee on Genetics, Health, and Society on oversight of genetic tests -- February 12, 2008

Comments to the Food and Drug Administration on the Draft Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays – October 5, 2007

Letter to Senate on National Institutes of Health (NIH) public access policy – September 17, 2007 

Letter to House and Senate Appropriations Committee members on National Institutes of Health (NIH) public access policy – June 19, 2007

Comments to the Secretary’s Advisory Committee on Genetics, Health, and Society on pharmacogenomics – June 1, 2007

Letter to the Chairs of the Senate and House Appropriations Subcommittees on Labor-HHS – May 21, 2007

Comments to the Food and Drug Administration (FDA) in response to their Draft Guidance on analyte specific reagents (ASRs) – February 22, 2007

Comments to the Food and Drug Administration (FDA) in response to their Draft Guidance on in vitro diagnostic multivariate index assays (IVDMIAs) – February 22, 2007.

Comments to the National Institutes of Health (NIH) in response to their request for information on data-sharing policy in relation to genome-wide association studies (GWAS) – November 30, 2006

Comments to the National Institutes of Health (NIH) in response to their request for information on the Roadmap initiative – November 17, 2006

Letter to the Centers for Medicare and Medicaid Services (CMS) requesting a genetics specialty under the Clinical Laboratory Improvement Amendments (CLIA) – October 11, 2006

Citizen’s petition to the Centers for Medicare and Medicaid Services (CMS) requesting a genetics specialty under the Clinical Laboratory Improvement Amendments (CLIA) – September 26, 2006 Press conference statement on the citizen’s petition to the Centers for Medicare and Medicaid Services (CMS) requesting a genetics specialty under the Clinical Laboratory Improvement Amendments (CLIA) – September 26, 2006 Letter to the Centers for Medicare and Medicaid Services (CMS) requesting a genetics specialty under the Clinical Laboratory Improvement Amendments (CLIA) – June 6, 2006

Letter to the Centers for Medicare and Medicaid Services (CMS) requesting a genetics specialty under the Clinical Laboratory Improvement Amendments (CLIA) – February 28, 2006

View policy statement archive